Publication | Closed Access

Effectiveness and safety of alternate-day simvastatin and fenofibrate on mixed hyperlipidemia

Cardiovascular DiseaseMixed HyperlipidemiaPharmacologyCardiovascular PharmacologyHyperlipidemiaPharmacotherapyClinical ChemistryMedicineAlternate-day SimvastatinDyslipidemia